{ }
Fortis Healthcare reported strong financial results for Q2 2024, with significant improvements in operating profit, cash flow, net sales, and profit after tax. The company achieved its highest operating profit to interest ratio in five quarters and generated record operating cash flow of Rs 1,100.10 crore. Despite a low Debtors Turnover Ratio, the overall performance indicates promising growth, leading to a 'Buy' recommendation from MarketsMOJO.
The Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics, raising its ownership to 89.2% for ₹1,780 crore, enhancing its integrated healthcare model. In a separate decision, CCI also sanctioned the merger of Diliigent Power with DB Power, aiming to streamline operations and strengthen their market position in power generation. These approvals highlight ongoing consolidation in India's healthcare and energy sectors.
Ashish Kyal, CMT and CEO of Waves Strategy Advisors, predicts a challenging start to Samvat 2081, suggesting that Nifty could breach its August low of 23,893 in November, potentially targeting 23,300. For Muhurat trading, he recommends Poly Medicure and Fortis Healthcare, highlighting Poly Medicure's recent breakout and consistent upward trend since October 28.
The Competition Commission of India (CCI) has approved Fortis Healthcare's acquisition of an additional 31.52% stake in Agilus Diagnostics, raising its ownership to 89.2% for ₹1,780 crore, enhancing its diagnostics services. Additionally, the CCI sanctioned the merger of Diliigent Power into DB Power, along with the reorganization of Decore Thermal Power, aimed at streamlining operations in the power generation sector. These approvals reflect ongoing consolidation efforts in India's healthcare and power industries.
The Elective Healthcare Services Market report offers a comprehensive analysis of industry growth, competitor landscapes, and the impact of COVID-19, alongside regulatory dynamics. It highlights key players, market segmentation, and future trends, providing actionable insights for stakeholders to navigate the evolving landscape effectively. The research utilizes both primary and secondary sources to deliver a detailed overview of market opportunities and challenges.
The Elective Healthcare Services market is poised for significant growth from 2024 to 2032, driven by rising disposable incomes, health awareness, and technological advancements. This market encompasses non-emergency medical procedures, including cosmetic surgery and fertility treatments, with key players like Fortis Healthcare and Apollo Hospital leading the sector. Comprehensive analysis covers market dynamics, segmentation, and regional insights, providing a detailed outlook for stakeholders.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.